Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02423395

Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis

Randomized Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Sherief Abd-Elsalam · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Muscle cramps are common in patients with liver disease and associated with significantly diminished quality of life. Patients with cirrhosis often experience muscle cramps with varied frequency and severity. The exact mechanisms by which they occur remain unclear, although a number of pathophysiological events unique to liver disease may contribute. Clinical studies have identified alterations in 3 areas: nerve function, energy metabolism, and plasma volume/electrolytes (1) Orphenadrine is an anticholinergic drug with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions. The combination of anticholinergic effects and CNS penetration make orphenadrine useful for pain of all etiologies, including from: radiculopathy, muscles, and headaches. \[3,4\]

Detailed description

Muscle cramps are common in patients with liver disease and associated with significantly diminished quality of life. Patients with cirrhosis often experience muscle cramps with varied frequency and severity. The exact mechanisms by which they occur remain unclear, although a number of pathophysiological events unique to liver disease may contribute. Clinical studies have identified alterations in 3 areas: nerve function, energy metabolism, and plasma volume/electrolytes \[1\]. Although a number of mechanisms for cramps in liver disease have been postulated and have been targeted by medical therapies, a clear picture of the causal events has not emerged. Several agents as vitamin E, human albumin, zinc, taurine, eperisone hydrochloride and branched-chain amino acids have shown some benefit in small uncontrolled studies, although large randomized controlled trials are lacking \[2\]. Orphenadrine is an anticholinergic drug with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions. The combination of anticholinergic effects and CNS penetration make orphenadrine useful for pain of all etiologies, including from: radiculopathy, muscles, and headaches. \[3,4\] Orphenadrine is structurally related to diphenhydramine and carries relatively stronger anticholinergic and weaker sedative properties, It is mostly excreted through the kidneys.\[5\]

Conditions

Interventions

TypeNameDescription
DRUGorphenadrineOrphenadrine in muscle cramps in cirrhotic patients
DRUGPlacebocalcium in muscle cramps in cirrhotic patients

Timeline

Start date
2015-01-01
Primary completion
2028-12-01
Completion
2028-12-01
First posted
2015-04-22
Last updated
2019-06-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02423395. Inclusion in this directory is not an endorsement.